Yosef Manla, MD, FESC

Grateful for the opportunity to contribute to the latest ISHLT Consensus Statement on antibodies and antibody-mediated rejection after heart transplantation, led by Dr. Jon Kobashigawa @SmidtHeart and Dr Andreas Zuckermann. 🫀In memory of Dr. @JigPatelMDPhD Link to statement : doi.org/10.1016/j.heal…

Honored to contribute to the @AST_info Fellows Task Force Report @amjtransplant on Recommendations to overcome barriers to transplant fellowship training in the US, led by Dr.Kobashigawa et al. Link: doi.org/10.1016/j.ajt.… The document included recommendations tailored around four areas of focus, including : 🔹Early and sustained exposure to transplant medicine 🔹Awareness through education 🔹Flexible fellowships and pathways to transplant 🔹Work–life resources @SmidtHeart @KiranKhush1 @spinneymd @afzal_aasim @ssfarouk @shelleyhallmd @MKIttlesonMD @DeirdreSawinski @AnjanaPillaiMD @virmani_sar @KidneyPrince

Consensus statement by Kobashigawa & Zuckermann et al. reviews evaluation/management of circulating #antibodies before & after #HeartTx, and antibody-mediated rejection. @SmidtHeart @ManlaYosef 🔗: jhltonline.org/article/S1053-…

Last week I had the great opportunity to present our work @SmidtHeart on HLA antibody Class and outcomes of sensitized Heart Transplant patient at #WorldTransplantCongress in SF #WTC2025 Grateful to my mentor Dr.Kobashigawa and the team for their support #Transplanation #OrganDonation | @AST_info | @ttsorg |

@DSadlerMD @CleClinicHVTI @Cancer_CCFla @FLASCO_ORG @ACCinTouch @ICOSociety @FloridaACC @drznahleh @escardio Congratulations Dr.Sadler!

Excited to report to our GCOR colleagues about the Grant awarded for Cancer Innovation by FDOH for Florida! @CleClinicHVTI @Cancer_CCFla @FLASCO_ORG @ACCinTouch @ICOSociety @FloridaACC @drznahleh @escardio

Don't let great research stall. With JCF Express: Court of Appeals you can submit your previously reviewed manuscript for an expedited editorial decision. No starting over. No wasted effort. Resubmit today hfsa.org/jcf-express-co…

@KiranKhush1 @ISHLT Thank you, Dr. Khush and the program committee, for an incredibly enriching learning experience at #ISHLT2025.

When the Program Chair has a poster and students, residents, and fellows have the podium…you know you have an unbiased review process! Great presentations on cutting-edge science at #ISHLT2025 ⁦@ISHLT⁩

Presented this at #ISHLT2025: In our single-center study @SmidtHeart , pre- heart transplant sensitization & older donor age were associated with immediate presentation of severe PGD-LV ⚠️. Immediate presentation = worse 30-day & 1-yr survival vs delayed presentation 📉.@ISHLT

Does Time Matter in #PGD presentation? @ISHLT @ManlaYosef ➡️ Study shows worse outcomes in immediate vs. delayed presentation w/ ⬇️ survival at 30d & 1 yr

Presenting our case series on variable responses to daratumumab for pre-transplant desensitization in adult heart transplant candidates #ISHLT2025 @ISHLT @SmidtHeart #transplantimmunology

2/🧵 🌍 Key themes identified: • 📊 Lack of high-quality, region-specific HF registry data • 🏥Balancing accessible care vs. centralized specialized care • ✅ Need for HF care accreditation & coordination across delivery centers • ⏱️ Improving prevention & timely diagnosis, especially in underserved communities • 👥Advancing multidisciplinary team-based care

Excited to share our recent paper summarizing @HFSA global roundtable discussions on heart failure innovation. Link: doi.org/10.36628/ijhf.… Grateful for the mentorship of Dr. Bader & Dr. Vest @NutritionHF and the opportunity to collaborate with HF Societies & leaders 🇺🇸 🇨🇦 🇨🇴 🇪🇺 🇬🇧 🇮🇳 🇯🇵 🇰🇷 🇦🇪worldwide to explore regional challenges and exchange solutions! 1/🧵 @HFSA @escardio @CanHFSociety @hfai20 @kshf_official @SmidtHeart @CleClinicHVTI @MarkDrazner @GMCRosano @yuya_matsue @Team_M_T @drjegomez @AniqueDucharme @BSHeartFailure

@MuhammadGhallab @CreightonCards @ACCinTouch Way to go !

Delighted to participate in the ACC25 with 4 projects with my great colleagues in Egypt and @CreightonCards @ACCinTouch #ACC25 #MedTwitter

New online! 🗒️Pleased to share that our State-of-the-Art Review on SSc associated cardiovascular disease is now published on @JScleroderma. Thank you @MarbanLab for the constant support. @scleroderma @SmidtHeart @YaleIMed journals.sagepub.com/eprint/DXQC2VW…

Excited to share that our paper “Macrophages Contribute to Cardiac Fibrosis and Diastolic Dysfunction in Systemic Sclerosis” is now on @JACCJournals🫀🔬. Thank you @MarbanLab for the mentorship and ongoing support. @SmidtHeart @YaleIMed jacc.org/doi/10.1016/j.…

@XMichaelJonesMD @JACCJournals @MarbanLab @SmidtHeart @YaleIMed @TheIbrahimLab @soussi_salwa @ThassioMesquita @AleCiulloPhD @rrogerslab Congratulations! Great work!

I am excited to share our recent publication @TheJHLT, demonstrating how therapeutic plasma exchange improves survival in patients experiencing severe primary graft dysfunction after heart transplantation. Link: doi.org/10.1016/j.heal… Beyond grateful to my mentor, Dr.Kobashigawa, and the team @SmidtHeart for the support and guidance

One of my unintended passions is now exploring: How do we make #cardioonc succeed, 1 program at a time? @yosefmanla @DSadlerMD et al reveal building blocks needed to build a program & how to leverage your local strengths & gaps in care for success! link.springer.com/article/10.100… 8/🧵

So happy to reconnect with You, Obada! Keep up the great work!